Watchlist Price Alert

Mersana Therapeutics Inc. (MRSN)

NASDAQ: MRSN · Real-Time Price · USD

0.36

0.04 (12.89%)

At close: May 12, 2025, 3:59 PM

0.36

2.13%

After-hours: May 12, 2025, 06:39 PM EDT

12.89% (1D)

Bid	0.36
Market Cap	44.54M
Revenue (ttm)	40.5M
Net Income (ttm)	-69.19M
EPS (ttm)	-0.56
PE Ratio (ttm)	-0.64
Forward PE	-0.46
Analyst	Buy

Ask	0.37
Volume	2,367,495
Avg. Volume (20D)	3,088,047
Open	0.32
Previous Close	0.32
Day's Range	0.32 - 0.37
52-Week Range	0.26 - 3.50
Beta	1.30

About MRSN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MRSN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Mersana Therapeutics Inc. is scheduled to release its earnings on May 15, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

-44.62%

Mersana Therapeutics shares are trading lower. The... Unlock content with Pro Subscription

6 months ago

+19.55%

Mersana Therapeutics shares are trading higher after the company reported better-than-expected Q3 financial results.

News

2 months ago · zacks.com

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates

Mersana Therapeutics, Inc. (MRSN) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.16 per share a year ago.